Last update: Sept. 19, 2016


High Risk for breastfeeding

Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives).
Read the Comment.

Nonopioid antitussive medication for which there are very few references.
It has been a cause of adverse reactions in children.

At latest update no published data on excretion into breast milk were found.

A known safer alternative should be preferred until more published data on this drug in relation to breastfeeding is available, especially during the neonatal period and in case prematurity.


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Oxolamine is also known as

Oxolamine in other languages or writings:


Oxolamine belongs to this group or family:


Main tradenames from several countries containing Oxolamine in its composition:


Variable Value Unit
Molecular weight 245 daltons
T1/2 3 - 4 hours


  1. Meyboom RH. Adverse reaction to drugs in children, experiences with "spontaneous monitoring" in The Netherlands. Bratisl Lek Listy. 1991 Abstract
  2. McEwen J, Meyboom RH, Thijs I. Hallucinations in children caused by oxolamine citrate. Med J Aust. 1989 Abstract

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM